OC
CTEV

Oppenheimer & Co’s Claritev Corp CTEV Stock Holding History

Oppenheimer & Co’s Portfolio CTEV Stock Details CTEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,729
Closed -$292K – 1689
2024
Q4 		$292K Buy
+19,729
New +$174K ﹤0.01% 1279

Other funds holding CTEV

HFCIV
H&F Corporate Investors VIII San Francisco, California $133M AUM 24.42% 1-Year Est. Return
AM
Ares Management Los Angeles, California $2.29B AUM 0.27% 1-Year Est. Return
PIF
Public Investment Fund Al Aqiq District, Riyadh, Saudi Arabia $37.9B AUM 7.98% 1-Year Est. Return
CP
CPV Partners Stamford, Connecticut $274M AUM 43.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BPCM
Beach Point Capital Management Santa Monica, California $258M AUM 20.26% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Oppenheimer & Co's CTEV Position: Q1 2025 in Review

Oppenheimer & Co sold out of Claritev Corp (CTEV) in Q1 2025, closing a stake of 19,729 shares — an estimated $292K sold.

Oppenheimer & Co first reported a position in CTEV in Q4 2024 and held it in 1 quarter. The position peaked at $292K in Q4 2024. 56 funds tracked by Wall St. Rank hold CTEV as of Q1 2025.

  • Oppenheimer & Co reported no remaining Claritev Corp position as of Q1 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 19,729 Claritev Corp shares in Q1 2025, an estimated $292K.
  • Oppenheimer & Co first reported a position in Claritev Corp in Q4 2024 and held it in 1 quarter.
  • Oppenheimer & Co's Claritev Corp position peaked at $292K in Q4 2024.
  • 56 funds tracked by Wall St. Rank held Claritev Corp as of Q1 2025.

Based on Oppenheimer & Co's 13F filing for Q1 2025, filed 23 Apr 2025.